Intelligent Total Cashflows From Investing Activities from 2010 to 2024

INBS Stock  USD 1.60  0.03  1.84%   
Intelligent Bio Total Cashflows From Investing Activities yearly trend continues to be comparatively stable with very little volatility. Total Cashflows From Investing Activities will likely drop to about -656 K in 2024. Total Cashflows From Investing Activities is the net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period. View All Fundamentals
 
Total Cashflows From Investing Activities  
First Reported
2010-12-31
Previous Quarter
-624.7 K
Current Value
-656 K
Quarterly Volatility
363.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 158.8 K or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 0.89, Dividend Yield of 0.0 or PTB Ratio of 0.37. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Total Cashflows From Investing Activities Growth Pattern

Below is the plot of the Total Cashflows From Investing Activities of Intelligent Bio Solutions over the last few years. It is the net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period. Intelligent Bio's Total Cashflows From Investing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
Total Cashflows From Investing Activities10 Years Trend
Slightly volatile
   Total Cashflows From Investing Activities   
       Timeline  

Intelligent Total Cashflows From Investing Activities Regression Statistics

Arithmetic Mean(258,352)
Coefficient Of Variation(140.81)
Mean Deviation325,802
Median(14,000)
Standard Deviation363,786
Sample Variance132.3B
Range866.2K
R-Value(0.77)
Mean Square Error57.2B
R-Squared0.60
Significance0.0007
Slope(62,937)
Total Sum of Squares1.9T

Intelligent Total Cashflows From Investing Activities History

2024-656 K
2023-624.7 K
2022-694.1 K
2020-880.2 K

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Total Cashflows From Investing Activities, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Cashflows From Investing Activities-624.7 K-656 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.